US 12,167,997 B2
Anti-oxidant compositions
V. A. Shiva Ayyadurai, Cambridge, MA (US); and Prabhakar Deonikar, Cambridge, MA (US)
Assigned to CytoSolve, Inc., Cambridge, MA (US)
Filed by CytoSolve, Inc., Cambridge, MA (US)
Filed on Mar. 17, 2023, as Appl. No. 18/185,711.
Claims priority of provisional application 63/321,522, filed on Mar. 18, 2022.
Prior Publication US 2023/0293486 A1, Sep. 21, 2023
Int. Cl. A61K 31/375 (2006.01); A61K 31/07 (2006.01); A61K 31/353 (2006.01); A61K 31/355 (2006.01); A61P 39/06 (2006.01)
CPC A61K 31/375 (2013.01) [A61K 31/07 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61P 39/06 (2018.01)] 5 Claims
 
1. A composition consisting of agents for reducing oxidative stress and optionally one or more excipients, diluents and carriers, wherein the agents consist of:
epicatechin present in an amount of about 0.75% w/w of the composition;
vitamin A present in an amount of about 4.5% w/w of the composition;
vitamin C present in an amount of about 66% w/w of the composition; and,
vitamin E present in an amount of about 28.75% w/w of the composition.